144 related articles for article (PubMed ID: 33171279)
1. (m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice.
Zhang R; Lao K; Lu B; Guo H; Cheng J; Chen P; Gou X
Peptides; 2021 Feb; 136():170442. PubMed ID: 33171279
[TBL] [Abstract][Full Text] [Related]
2. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
Zhang RS; He Z; Jin WD; Wang R
Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
[TBL] [Abstract][Full Text] [Related]
3. Effect of (m)VD-hemopressin against Aβ1-42-induced oxidative stress and apoptosis in mouse hippocampal neurons.
Zhang R; Zheng Y; Hu F; Meng X; Lv B; Lao K; Gao X; Zhang X; Gou X
Peptides; 2020 Feb; 124():170185. PubMed ID: 31730791
[TBL] [Abstract][Full Text] [Related]
4. (m) RVD-hemopressin (α) Ameliorated Oxidative Stress, Apoptosis and Damage to the BDNF/TrkB/Akt Pathway Induced by Scopolamine in HT22 Cells.
Zhang R; He X; Cheng J; Zhang X; Han C; Liu Y; Chen P; Wang Y
Neurotox Res; 2023 Dec; 41(6):627-637. PubMed ID: 37971633
[TBL] [Abstract][Full Text] [Related]
5. Anorexigenic effects induced by RVD-hemopressin(α) administration.
Ferrante C; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Martinotti S; Mollica A; Macedonio G; Stefanucci A; Dvorácskó S; Tömböly C; De Petrocellis L; Vacca M; Brunetti L; Orlando G
Pharmacol Rep; 2017 Dec; 69(6):1402-1407. PubMed ID: 29145068
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
[TBL] [Abstract][Full Text] [Related]
7. Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice.
Li XH; Lin ML; Wang ZL; Wang P; Tang HH; Lin YY; Li N; Fang Q; Wang R
Neurogastroenterol Motil; 2016 Jun; 28(6):891-9. PubMed ID: 26991932
[TBL] [Abstract][Full Text] [Related]
8. Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.
Pan JX; Wang ZL; Li N; Han ZL; Li XH; Tang HH; Wang P; Zheng T; Fang Q; Wang R
Neurosci Lett; 2014 Aug; 578():187-91. PubMed ID: 25010019
[TBL] [Abstract][Full Text] [Related]
9. Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.
Nedaei SE; Rezayof A; Pourmotabbed A; Nasehi M; Zarrindast MR
Behav Brain Res; 2016 Sep; 311():183-191. PubMed ID: 27230394
[TBL] [Abstract][Full Text] [Related]
10. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
[TBL] [Abstract][Full Text] [Related]
11. Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.
Macedonio G; Stefanucci A; Maccallini C; Mirzaie S; Novellino E; Mollica A
Protein Pept Lett; 2016; 23(12):1045-1051. PubMed ID: 27748182
[TBL] [Abstract][Full Text] [Related]
12. Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides.
Wei F; Zhao L; Jing Y
Neuropeptides; 2020 Feb; 79():101998. PubMed ID: 31831183
[TBL] [Abstract][Full Text] [Related]
13. Central functional response to the novel peptide cannabinoid, hemopressin.
Dodd GT; Worth AA; Hodkinson DJ; Srivastava RK; Lutz B; Williams SR; Luckman SM
Neuropharmacology; 2013 Aug; 71():27-36. PubMed ID: 23542442
[TBL] [Abstract][Full Text] [Related]
14. Characterization of pepcan-23 as pro-peptide of RVD-hemopressin (pepcan-12) and stability of hemopressins in mice.
Glasmacher S; Gertsch J
Adv Biol Regul; 2021 May; 80():100808. PubMed ID: 33799079
[TBL] [Abstract][Full Text] [Related]
15. Hemopressin as a breakthrough for the cannabinoid field.
Heimann AS; Dale CS; Guimarães FS; Reis RAM; Navon A; Shmuelov MA; Rioli V; Gomes I; Devi LL; Ferro ES
Neuropharmacology; 2021 Feb; 183():108406. PubMed ID: 33212113
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice.
Zheng T; Zhang T; Zhang R; Wang ZL; Han ZL; Li N; Li XH; Zhang MN; Xu B; Yang XL; Fang Q; Wang R
Neuropeptides; 2017 Jun; 63():83-90. PubMed ID: 28010996
[TBL] [Abstract][Full Text] [Related]
17. Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats.
Leone S; Recinella L; Chiavaroli A; Martinotti S; Ferrante C; Mollica A; Macedonio G; Stefanucci A; Dvorácskó S; Tömböly C; De Petrocellis L; Vacca M; Brunetti L; Orlando G
Pharmacol Rep; 2017 Dec; 69(6):1247-1253. PubMed ID: 29128806
[TBL] [Abstract][Full Text] [Related]
18. The hypotensive effect of intrathecally injected (m)VD-hemopressin(α) in urethane-anesthetized rats.
Li XH; Li N; Wang ZL; Pan JX; Han ZL; Chang XM; Tang HH; Wang P; Wang R; Fang Q
Peptides; 2014 Jun; 56():45-51. PubMed ID: 24681436
[TBL] [Abstract][Full Text] [Related]
19. Effects of RVD-hemopressin (α) on feeding and body weight after standard or cafeteria diet in rats.
Leone S; Ferrante C; Recinella L; Chiavaroli A; Mollica A; Tömböly C; Stefanucci A; Dimmito MP; Dvorácskó S; Verratti V; De Petrocellis L; Orlando G; Brunetti L
Neuropeptides; 2018 Dec; 72():38-46. PubMed ID: 30396596
[TBL] [Abstract][Full Text] [Related]
20. Effects of central RVD-hemopressin(α) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat.
Recinella L; Chiavaroli A; Ferrante C; Mollica A; Macedonio G; Stefanucci A; Dimmito MP; Dvorácskó S; Tömböly C; Brunetti L; Orlando G; Leone S
Pharmacol Rep; 2018 Aug; 70(4):650-657. PubMed ID: 29902669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
